2,053
Views
4
CrossRef citations to date
0
Altmetric
Articles

Effect of Hashimoto's thyroiditis on the extent of the ablation zone in early stages of ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma: a large cohort study of 772 patients

ORCID Icon, ORCID Icon, , ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 397-404 | Received 06 Sep 2021, Accepted 07 Feb 2022, Published online: 24 Feb 2022

References

  • Lim H, Devesa SS, Sosa JA, et al. Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA. 2017;317(13):1338–1348.
  • Wang J, Yu F, Shang Y, et al. Thyroid cancer: incidence and mortality trends in China, 2005–2015. Endocrine. 2020;68(1):163–173.
  • Grodski S, Brown T, Sidhu S, et al. Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery. 2008;144(6):1038–1043; discussion 43.
  • Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet. 2016;388(10061):2783–2795.
  • Hedinger C, Williams ED, Sobin LH. The WHO Histological Classification of Thyroid Tumors: a commentary on the second edition. Cancer. 1989;63(5):908–911.
  • Ito Y, Miyauchi A, Oda H. Low-risk papillary microcarcinoma of the thyroid: a review of active surveillance trials. Eur J Surg Oncol. 2018;44(3):307–315.
  • Leboulleux S, Tuttle RM, Pacini F, et al. Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? Lancet Diabetes Endocrinol. 2016;4(11):933–942.
  • Luster M, Aktolun C, Amendoeira I, et al. European perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: proceedings of an interactive international symposium. Thyroid. 2019;29(1):7–26.
  • Haser GC, Tuttle RM, Su HK, et al. Active surveillance for papillary thyroid microcarcinoma: new challenges and opportunities for the health care system. Endocr Pract. 2016;22(5):602–611.
  • Tong M, Li S, Li Y, et al. Efficacy and safety of radiofrequency, microwave and laser ablation for treating papillary thyroid microcarcinoma: a systematic review and meta-analysis. Int J Hyperthermia. 2019;36(1):1278–1286.
  • Singh B, Shaha AR, Trivedi H, et al. Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery. 1999;126(6):1070–1076; discussion 6–7.
  • Vita R, Ieni A, Tuccari G, et al. The increasing prevalence of chronic lymphocytic thyroiditis in papillary microcarcinoma. Rev Endocr Metab Disord. 2018;19(4):301–309.
  • Ieni A, Vita R, Magliolo E, et al. One-third of an archivial series of papillary thyroid cancer (years 2007–2015) has coexistent chronic lymphocytic thyroiditis, which is associated with a more favorable tumor-node-metastasis staging. Front Endocrinol. 2017;8(337):337.
  • Resende de Paiva C, Gronhoj C, Feldt-Rasmussen U, et al. Association between Hashimoto's thyroiditis and thyroid cancer in 64,628 patients. Front Oncol. 2017;7:53.
  • Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4–5):391–397.
  • Ni Y, Mulier S, Miao Y, et al. A review of the general aspects of radiofrequency ablation. Abdom Imaging. 2005;30(4):381–400.
  • Liu Z, Ahmed M, Weinstein Y, et al. Characterization of the RF ablation-induced 'oven effect': the importance of background tissue thermal conductivity on tissue heating. Int J Hyperthermia. 2006;22(4):327–342.
  • Ahmed M, Liu Z, Humphries S, et al. Computer modeling of the combined effects of perfusion, electrical conductivity, and thermal conductivity on tissue heating patterns in radiofrequency tumor ablation. Int J Hyperthermia. 2008;24(7):577–588.
  • Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol. 2000;174(2):323–331.
  • Ahmed M, Brace CL, Lee FT Jr., et al. Principles of and advances in percutaneous ablation. Radiology. 2011;258(2):351–369.
  • Wang H, Lee JC, Cao K, et al. What is the difference in ablation zone of multi-bipolar radiofrequency ablation between liver cirrhosis and normal liver background? A prospective clinical study. Int J Hyperthermia. 2020;37(1):1248–1259.
  • Aysan E, Idiz UO, Akbulut H, et al. Single-session radiofrequency ablation on benign thyroid nodules: a prospective single center study: radiofrequency ablation on thyroid. Langenbecks Arch Surg. 2016;401(3):357–363.
  • Zhang Y, Zhang MB, Luo YK, et al. Effect of chronic lymphocytic thyroiditis on the efficacy and safety of ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma. Cancer Med. 2019;8(12):5450–5458.
  • Nikfarjam M, Muralidharan V, Christophi C. Mechanisms of focal heat destruction of liver tumors. J Surg Res. 2005;127(2):208–223.
  • Gillams A. Tumour ablation: current role in the liver, kidney, lung and bone. Cancer Imaging. 2008;8(Spec. No. A):S1–S5.
  • Izzo F, Granata V, Grassi R, et al. Radiofrequency ablation and microwave ablation in liver tumors: an update. Oncologist. 2019;24(10):e990–e1005.
  • Mahnken AH, Gunther RW, Tacke J. Radiofrequency ablation of renal tumors. Eur Radiol. 2004;14(8):1449–1455.
  • Joniau S, Tsivian M, Gontero P. Radiofrequency ablation for the treatment of small renal masses: safety and oncologic efficacy. Minerva Urol Nefrol. 2011;63(3):227–236.
  • Cantwell CP, Obyrne J, Eustace S. Current trends in treatment of osteoid osteoma with an emphasis on radiofrequency ablation. Eur Radiol. 2004;14(4):607–617.
  • Li G, Xue M, Chen W, et al. Efficacy and safety of radiofrequency ablation for lung cancers: a systematic review and meta-analysis. Eur J Radiol. 2018;100:92–98.
  • Rossi S, Fornari F, Pathies C, et al. Thermal lesions induced by 480 kHz localized current field in guinea pig and pig liver. Tumori. 1990;76(1):54–57.
  • McGahan JP, Browning PD, Brock JM, et al. Hepatic ablation using radiofrequency electrocautery. Invest Radiol. 1990;25(3):267–270.
  • Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer. 1994;74(3):817–825.
  • Ohyama M, Katsuda K, Nobori T, et al. Treatment of head and neck tumors by contact Nd–YAG laser surgery. Auris Nasus Larynx. 1985;12(Suppl. 2):S138–S142.
  • Anzai Y, Lufkin R, DeSalles A, et al. Preliminary experience with MR-guided thermal ablation of brain tumors. AJNR Am J Neuroradiol. 1995;16(1):39–48; discussion 9–52.
  • Pacella CM, Bizzarri G, Guglielmi R, et al. Thyroid tissue: US-guided percutaneous interstitial laser ablation—a feasibility study. Radiology. 2000;217(3):673–677.
  • Dupuy DE, Monchik JM, Decrea C, et al. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery. 2001;130(6):971–977.
  • Kim YS, Rhim H, Tae K, et al. Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience. Thyroid. 2006;16(4):361–367.
  • Kim JH, Baek JH, Lim HK, et al. 2017 thyroid radiofrequency ablation guideline: Korean Society of Thyroid Radiology. Korean J Radiol. 2018;19(4):632–655.
  • Rangel L, Volpi LM, Stabenow E, et al. Radiofrequency for benign and malign thyroid lesions. World J Otorhinolaryngol Head Neck Surg. 2020;6(3):188–193.
  • Cesareo R, Palermo A, Pasqualini V, et al. Radiofrequency ablation for the management of thyroid nodules: a critical appraisal of the literature. Clin Endocrinol. 2017;87(6):639–648.
  • Radzina M, Cantisani V, Rauda M, et al. Update on the role of ultrasound guided radiofrequency ablation for thyroid nodule treatment. Int J Surg. 2017;41(Suppl. 1):S82–S93.
  • Yan L, Lan Y, Xiao J, et al. Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients. Eur Radiol. 2021;31(2):685–694.
  • Chen J, Cao J, Qiu F, et al. The efficacy and the safety of ultrasound-guided ablation therapy for treating papillary thyroid microcarcinoma. J Cancer. 2019;10(21):5272–5282.
  • Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid. 2016;26(11):1581–1587.
  • Wang L, Xu D, Yang Y, et al. Safety and efficacy of ultrasound-guided percutaneous thermal ablation in treating low-risk papillary thyroid microcarcinoma: a pilot and feasibility study. J Cancer Res Ther. 2019;15(7):1522–1529.
  • Cao XJ, Liu J, Zhu YL, et al. Efficacy and safety of thermal ablation for solitary T1bN0M0 papillary thyroid carcinoma: a multicenter study. J Clin Endocrinol Metab. 2020;106(2):e573–e581.
  • Shen K, Xue S, Xie Y, et al. Comparison of thermal ablation and routine surgery for the treatment of papillary thyroid microcarcinoma: a systematic review and meta-analysis. Int J Hyperthermia. 2020;37(1):913–924.
  • Rennert J, Wiesinger I, Beyer LP, et al. Color coded perfusion analysis and microcirculation imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following thermal ablative techniques of primary and secondary liver malignancies. Clin Hemorheol Microcirc. 2019;73(1):73–83.
  • Zhang L, Zhou W, Zhan W, et al. Percutaneous laser ablation of unifocal papillary thyroid microcarcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in assessing local therapeutic response. World J Surg. 2018;42(8):2476–2484.
  • da Silva NPB, Beyer LP, Hottenrott MC, et al. Efficiency of contrast enhanced ultrasound for immediate assessment of ablation status after intraoperative radiofrequency ablation of hepatic malignancies. Clin Hemorheol Microcirc. 2017;66(4):357–368.
  • Yan L, Luo Y, Xiao J, et al. Non-enhanced ultrasound is not a satisfactory modality for measuring necrotic ablated volume after radiofrequency ablation of benign thyroid nodules: a comparison with contrast-enhanced ultrasound. Eur Radiol. 2021;31(5):3226–3236.
  • Song KD, Lee MW, Rhim H, et al. Chronological changes of radiofrequency ablation zone in rabbit liver: an in vivo correlation between gross pathology and histopathology. Br J Radiol. 2017;90(1071):20160361.
  • Gemeinhardt O, Poch FG, Hiebl B, et al. Comparison of bipolar radiofrequency ablation zones in an in vivo porcine model: correlation of histology and gross pathological findings. Clin Hemorheol Microcirc. 2017;64(3):491–499.